Argonaute 2 Recombinant Rabbit Monoclonal Antibody [JF0992]
Usd: 205 Special Discount
Specification
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_ET1702-39_Europe.pdf
- No MSDS Found
Overview
Product Name
Argonaute 2 Recombinant Rabbit Monoclonal Antibody [JF0992]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within Human Argonaute 2 aa 361-404 / 859.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, FC, IP
Target Molecular Weight
Predicted band size: 97 kDa
Positive Control
HCT 116 cell lysate, HeLa cell lysate, HCT 116, RAW264.7, C6, mouse kidney tissue, mouse stomach tissue, human liver tissue.
Conjugation
unconjugated
Clone Number
JF0992
RRID
Reactivity Data
Verified (internally validated)
Reported in literature (not internally validated)
Predicted reactive (based on sequence homology)
Not recommended (failed internal validation)
| WB | IHC-P | FC | IF-Cell | IP | |
|---|---|---|---|---|---|
| human |
|
|
|
|
|
| mouse |
|
|
|
|
|
| rat |
|
|
|
|
|
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.1% BSA, 40% Glycerol, 0.2% Proclean 950.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000
-
IF-Cell
-
1:50-1:200
-
IF-Tissue
-
1:50-1:200
-
IHC-P
-
1:1,000-1:4,000
-
FC
-
1:50-1:100
-
IP
-
1-2μg/sample
Target
Function
Eukaryotic translation initiation factor 2C (eIF2C) proteins (argonaute family) influence RNA interference (RNAi) as components of the RNA-inducible silencing complex (RISC) or microRNA (miRNA)-containing ribonucleoprotein particle (miRNP). Small RNAs, including small interfering RNAs (siRNAs) and miRNAs, can silence target genes through mechanisms that utilize RISC or miRNP particles. eIF2C1 (argonaute 1, AGO1, eIF2C, GERP95, Q99) and Dicer1 play a coordinated role in siRNA-mediated gene silencing. eIF2C2 (Slicer, argonaute 2, AGO2, Q10) is a RISC component that can concentrate in cytoplasmic processing bodies (P-bodies) and catalyze mRNA cleavage. Mammalian P-bodies contain mRNAs and have an association with miRNA-induced translational silencing and siRNA-induced mRNA degradation. Additional eIF2C proteins include eIF2C3 (argonaute 3, AGO3), eIF2C4 (argonaute 4, AGO4) and meIF2c5 (mouse argonaute 5).
Background References
1. Atwood BL et al. Human Argonaute 2 Is Tethered to Ribosomal RNA through MicroRNA Interactions. J Biol Chem 291:17919-28 (2016).
2. Marin-Vicente C et al. RRP6/EXOSC10 is required for the repair of DNA double-strand breaks by homologous recombination. J Cell Sci 128:1097-107 (2015).
Sequence Similarity
Belongs to the argonaute family. Ago subfamily.
Post-translational Modification
Hydroxylated. 4-hydroxylation appears to enhance protein stability but is not required for miRNA-binding or endonuclease activity.
Subcellular Location
Cytoplasm, Nucleus.
Synonyms
Ago 2 antibody
AGO2_HUMAN antibody
Argonaute 2 antibody
argonaute 2, RISC catalytic component antibody
Argonaute RISC catalytic component 2 antibody
Argonaute2 antibody
CTA-204B4.6 antibody
dAgo2 antibody
eIF 2C 2 antibody
eIF-2C 2 antibody
ExpandAgo 2 antibody
AGO2_HUMAN antibody
Argonaute 2 antibody
argonaute 2, RISC catalytic component antibody
Argonaute RISC catalytic component 2 antibody
Argonaute2 antibody
CTA-204B4.6 antibody
dAgo2 antibody
eIF 2C 2 antibody
eIF-2C 2 antibody
eIF2C 2 antibody
Eif2c2 antibody
Eukaryotic translation initiation factor 2C 2 antibody
Eukaryotic translation initiation factor 2C subunit 2 antibody
hAgo2 antibody
MGC3183 antibody
PAZ Piwi domain protein antibody
PPD antibody
Protein argonaute-2 antibody
Protein slicer antibody
Q10 antibody
Slicer protein antibody
CollapseImages
-
☑ Knockout (KO)
All lanes: Western blot analysis of Ago2 with anti-Ago2 antibody [JF0992] (ET1702-39) at 1:500 dilution.
Lane 1: Wild-type CHO whole cell lysate.
Lane 2: Ago2 knockout CHO whole cell lysate.
ET1702-39 was shown to specifically react with Ago2 in wild-type CHO cells. No band was observed when Ago2 knockout samples were tested. Wild-type and Ago2 knockout samples were subjected to SDS-PAGE. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary Anti-Ago2 antibody (ET1702-39, 1/500) and Anti-Vinculin antibody (ET1705-94, 1/5,000) were used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG H&L (HRP) Secondary Antibody (HA1001) at 1:200,000 dilution was used for 1 hour at room temperature.
Cell lysate was provided by Ubigene Biosciences (Ubigene Biosciences Co., Ltd., Guangzhou, China). -
Western blot analysis of Argonaute 2 on different lysates with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/2,000 dilution.
Lane 1: HCT 116 cell lysate
Lane 2: HeLa cell lysate
Lysates/proteins at 15 µg/Lane.
Predicted band size: 97 kDa
Observed band size: 97 kDa
Exposure time: 1 minute 40 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1702-39) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of HCT 116 cells labeling Argonaute 2 with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of RAW264.7 cells labeling Argonaute 2 with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C6 cells labeling Argonaute 2 with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/4,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1702-39) at 1/4,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse stomach tissue with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/4,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1702-39) at 1/4,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human liver tissue with Rabbit anti-Argonaute 2 antibody (ET1702-39) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1702-39) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Flow cytometric analysis of HCT 116 cells labeling Argonaute 2.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1702-39, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Flow cytometric analysis of RAW264.7 cells labeling Argonaute 2.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1702-39, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Flow cytometric analysis of C6 cells labeling Argonaute 2.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1702-39, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Citation
-
Exosomes-Transferred lncRNA H19 Reverses Osimertinib Resistance by Upregulating PTEN via Sponging miR-148-3p in Non-Small Cell Lung Cancer
Journal: Oncology Research
DOI: 10.32604/or.2026.078665
IF: 4.6
Application: WB
Reactivity: Human
Publish date: 2026 May
-
miR-21-5p attenuates hyperoxia-induced lung injury by modulating YAP1-dependent ferroptosis
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2026.1804152
IF: 5.4
Application: WB
Reactivity:
Publish date: 2026 May
-
WTAP Mediated m6A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma
Journal: Advanced Science
DOI: 10.1002/advs.202506529
IF: 14.1
Application:
Reactivity:
Publish date: 2025 Jun
-
miR-135b-5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial-Mesenchymal Transition
Journal: Molecular Carcinogenesis
DOI: 10.1002/mc.23914
IF: 3
Application: RIP
Reactivity: Human
Publish date: 2025 Apr
-
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Journal: Molecular Cancer
DOI:
IF: 27.7
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
Epstein–Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1
Journal: Journal Of Biological Chemistry
DOI: 10.1016/j.jbc.2023.105082
IF: 4.8
Application: IP
Reactivity: Human
Publish date: 2023 Jul
-
circ_0003204 regulates the osteogenic differentiation of human adipose-derived stem cells via miR-370-3p/HDAC4 axis
Journal: International Journal Of Oral Science
DOI:
IF: 6.344
Application: RIP
Reactivity: Human
Publish date: 2022 Jun
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"